P53-independent anisomycin induced G1 arrest and apoptosis in L1210 cell lines

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 421-428

  He, Ai Wu Ruth ^a   Cory, Joseph G ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Anisomycin; Apoptosis; G1 arrset; p53

Indexed keywords

ANISOMYCIN; CAFFEINE; CELL DNA; CELL PROTEIN; CYCLOHEXIMIDE; DEOXYADENOSINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN P53; PROTEIN SYNTHESIS INHIBITOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG RESISTANCE; LEUKEMIA L 1210; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION;

ANIMALS; ANISOMYCIN; APOPTOSIS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CAFFEINE; CYCLOHEXIMIDE; G1 PHASE; LEUKEMIA L1210; MICE; NF-KAPPA B; PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITORS; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032897821     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Motokura T and Arnold A: Cyclin D and oncogenesis. Curr Opin Genet Dev 3: 5-10, 1993.
2. Nigg EA: Targets of cyclin-dependent protein kinases. Curr Opin Cell Biol 5: 187-193, 1993.
3. Sherr CJ: Mammalian GI cyclins. Cell 73: 1059-1065, 1993.
4. Solomon MJ: Activation of the various cyclin/cdc2 protein kinases. Curr Opin Cell Biol 5: 180-186, 1993.
5. Sherr CJ: GI phase progression: cycling on cue. Cell 79: 551-555, 1994.
6. Sherr CJ and Roberts JM: Inhibitors of mammalian GI cyclin-dependent kinases. Genes Dev 9: 1149-1163, 1995.
7. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR: The E2F transcription factor is a cellular target for the Rb protein. Cell 65: 1053-1062, 1991.
8. Dou QP, Zhao S, Levin AH, Wang J, Helin K, Pardee AB: GI/S-regulated E2F-containing protein complexes bind to the mouse thymidine kinase gene promoter. J Biol Chem 269: 1306-1313, 1994.
9. Li LJ, Naeve GS, Lee AS: Temporal regulation of cyclin a-P107 and P33-cdk-2 complexes binding to a human thymidine kinase promoter element important for GI-S phase transcriptional regulation. Proc Natl Acad Sci USA 90: 3554-3558, 1993.
10. Pearson BE, Nasheuer HP, Wang TSF: Human DNA polymerase alpha gene sequences controlling expression in cycling and serum-stimulated cells. Mol Cell Biol 11: 2081-2095, 1991.
11. Diller L, Kassel J, Nelson CE, Gryka MA, Litwak G, Gebhardt M, Bressac B, Ozturk M, Baker SJ, Vogelstein B, et al: p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol 10: 5772-5781, 1990.
12. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
13. White E: Death-defying acts: A meeting review on apoptosis (Fifth Annual Pezcoller Symposium "Apoptosis" Trento, Italy, June 9-11, 1993). Genes & Devel 7: 2277-2284, 1993.
14. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P: Mice lacking p21-CIP1/WAF1 undergo normal development, but are defective in GI checkpoint control. Cell 82: 675-684, 1995.
15. Pietenpol JA, Tokino T, Thagalingam S, El-Deiry WS, Kinzler KW, Vogelstein B: Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc Natl Acad Sci USA 91: 1998-2002, 1994.
16. Vogelstein B, Kinzler KW: p53 function and dysfunction. Cell 70: 523-526, 1992.
17. Smith ML, Kontny HU, Zhan O, Sreenath A, O'Connor PM, Fornace AJ, Jr: Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to U.V.-irradiation or cisplatin. Oncogene 13: 2255-2263, 1996.
18. Dulic VK, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ, Reed SI: p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced GI arrest. Cell 76: 1013-1023, 1994.
19. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 cdk-interacting protein Cip1 is a potent inhibitor of GI cyclin-dependent kinases. Cell 75: 805-816, 1993.
20. Xiong Y, Hannon GJ, Zhang H, Casso D, Kohayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704, 1993.
21. Zhang, Grasso L, Mcclain CD, Gambel AM, Cha Y, Travali S, Deisseroth AB, Mercer WE: p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res 55: 668-674, 1995.
22. Arends MJ, Morris RG, Wyllie AH: Apoptosis. The role of the endonuclease. Am J Pathol 136: 593-608, 1990.
23. Kerr JG, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
24. Ryan JJ, Danish R, Gottlieb CA, Clarke MF: Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells. Mol Cell Biol 13: 711-719, 1993.
25. Yonish Rouach, Grunwald D, Wilder S, Kimchi A, May E, Lawrence JJ, May P, Oren M: p53-mediated cell death relationship to cell cycle control. Mol Cell Biol 13: 1415-1423, 1993.
26. Agarwal ML, Agarwal A, Taylor WR, Stark GR: p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 92: 8493-8497, 1995.
27. Shihata Y, Nishimura S, Okuyama A, Makamura T: p53-independent induction of apoptosis by cyclin-dependent kinase inhibition. Cell Growth Different 7: 887-891, 1996.
28. Cochran BH, Zullo J, Verma IM, Stiles CD: Expression of the c-fos gene and of a fos-related gene is stimulated by platelet-derived growth factor [published erratum appears in Science 1986, Apr 18, 232(4748): 307] Science 226: 1080-1082, 1984.
29. Kelly K, Cochran BH, Stiles CD, Leder P: Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35: 603-610, 1983.
30. Kruijer W, Cooper JA, Hunter T, Verma IM: Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein. Nature 312: 711-716, 1984.
31. Muller R, Bravo R, Burckhardt J, Curran T: Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature 312: 716-720, 1984.
32. Frick KK, Womer RB, Scher CD: Platelet-derived growth factor-induced c-myc RNA expression. Analysis of an inducible pathway independent of protein kinase C J Biol Chem 263: 2948-2952, 1988.
33. Mahadevan LC, Edwards DR: Signalling and superinduction [letter]. Nature 349: 747-748, 1991.
34. Zinck, Cahill MA, Kracht M, Sachsenmaier C, Hipskind RA, Nordheim AR: Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converege on Elk-1. Mol Cell Biol 15: 4930-4938, 1995.
35. Pestka S: Inhibitors of ribosome functions. Annu. Rev. Microbiol. 25: 487-562, 1971.
36. Cory JG, Cory AH, Long SD, Carter GL, Johnson, CE: Altered steady-state levels of the messenger RNAs for c-Myc and p53 in L1210 cell lines resistant to deoxyadenosine. Cancer Res 52: 2000-2003, 1992.
37. Carter GL, Cory JG: Selective resistance of L1210 cell lines to inhibitors directed at the subunits of ribonucleotide reductase. Adv Enzyme Regul 29: 123-139, 1989.
38. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
39. Krishan A: Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 66: 188-193, 1975.
40. Dou QP, An B, Will PL: Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G-1 arrest and apoptosis. Proc Natl Acad Sci USA 92: 9019-9023, 1995.
41. Lock RB, Galperina OV, Feldhoff RC, Rhodes U: Concentration-dependent differences in the mechanisms by which caffeine potentiates etoposide cytotoxicity in HeLa cells. Cancer Res 54: 4933-4939, 1994.
42. Lane DP: Cancer. p53, guardian of the genome [news; comment] [see comments]. Nature 358: 15-16, 1992.
43. Beg AA, Baltimore D: An essential role for NFκB in preventing TNF-α-induced cell death. Science 274: 782-784, 1996.
44. VanAntwerp DJ, Martin SJ, Verma M, Green DR: Inhibition of TNF-induced apoptosis by NFκB. Trends Cell Biol 8: 107-111, 1998.
45. Wang CY, Mayo MW, Baldwin AS: TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NFκB. Science 274 784-787, 1996.
46. Barratt MJ, Hazzalin CA, Zhelev N, Mahadevan LC: A mitogen-and anisomycin-stimulated kinase phosphorylates HMG-14 in its basic amino-terminal domain in vivo and on isolated mononucleosomes. Embo J 13: 4524-4535, 1994.
47. Cano E, Hazzalin CA, Kardalinou E, Buckle RS, Mahadevan LC: Neither ERK nor JNK/SAMP MAP kinase subtypes are essential for histone H3/HMG-14 phosphorylation of c-fos and c-jun induction. J Cell Science 108: 3599-3609, 1995.
48. Cano E, Hazalin CA, Mahadevan LC: Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun. Mol Cell Biol 14: 7352-7362, 1994.
49. Edwards DR, Mahadevan LC: Protein synthesis inhibitors differentially superinduce c-fos and c-jun by three distinc mechanisms lack of evidence for labile repressers. EMBO J 11: 2415-2424, 1992.
50. Cory JG, He AWR, Cory AH: Deoxyadenosine-resistant mouse leukemia L1210 cell lines with alterations in early response genes and p53. Anticancer Res 16: 3483-3490, 1996.